Prognostic impact offibroblast growth factor receptor 2gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers-Reference-Cited by-同舟云学术

Prognostic impact offibroblast growth factor receptor 2gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers

Published:2016-10-27 Issue:20 Volume:8 Page:33844-33854
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Seo Seyoung¹,Park Seong Joon¹,Ryu Min-Hee¹,Park Sook Ryun¹,Ryoo Baek-Yeol¹,Park Young Soo²,Na Young-Soon³,Lee Chae-Won³,Lee Ju-Kyung³,Kang Yoon-Koo¹

Affiliation:

1. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

2. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

3. Asan Institute for Life Science, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer;Biomedicines;2024-05-17

2. Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL;Cancers;2023-08-20

3. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer;Cancers;2023-08-15

4. A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer;Investigational New Drugs;2023-03-13

5. Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors;Cancer Science;2022-12-04